162 related articles for article (PubMed ID: 38212672)
1. Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot study.
Youngster I; Eshel A; Geva M; Danylesko I; Henig I; Zuckerman T; Fried S; Yerushalmi R; Shem-Tov N; Fein JA; Bomze D; Shimoni A; Koren O; Shouval R; Nagler A
Bone Marrow Transplant; 2024 Mar; 59(3):409-416. PubMed ID: 38212672
[TBL] [Abstract][Full Text] [Related]
2. [Clinical study of 19 cases of steroid-refractory gastrointestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with fecal microbiota transplantation].
Zheng YY; Yang XT; Lin GQ; Bian MR; Si YJ; Zhang XX; Zhang YM; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):401-407. PubMed ID: 37550190
[No Abstract] [Full Text] [Related]
3. Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut.
Kakihana K; Fujioka Y; Suda W; Najima Y; Kuwata G; Sasajima S; Mimura I; Morita H; Sugiyama D; Nishikawa H; Hattori M; Hino Y; Ikegawa S; Yamamoto K; Toya T; Doki N; Koizumi K; Honda K; Ohashi K
Blood; 2016 Oct; 128(16):2083-2088. PubMed ID: 27461930
[TBL] [Abstract][Full Text] [Related]
4. Treatment of intestinal graft-versus-host disease with unrelated donor fecal microbiota transplantation capsules: A case report.
Mao D; Jiang Q; Sun Y; Mao Y; Guo L; Zhang Y; Man M; Ouyang G; Sheng L
Medicine (Baltimore); 2020 Sep; 99(38):e22129. PubMed ID: 32957333
[TBL] [Abstract][Full Text] [Related]
5. Fecal microbiota transfer for refractory intestinal graft-versus-host disease - Experience from two German tertiary centers.
Goeser F; Sifft B; Stein-Thoeringer C; Farowski F; Strassburg CP; Brossart P; Higgins PG; Scheid C; Wolf D; Holderried TAW; Vehreschild MJGT; Cruz Aguilar MR
Eur J Haematol; 2021 Aug; 107(2):229-245. PubMed ID: 33934412
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial.
Zhao Y; Li X; Zhou Y; Gao J; Jiao Y; Zhu B; Wu D; Qi X
Front Immunol; 2021; 12():678476. PubMed ID: 34220825
[TBL] [Abstract][Full Text] [Related]
7. Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity.
DeFilipp Z; Peled JU; Li S; Mahabamunuge J; Dagher Z; Slingerland AE; Del Rio C; Valles B; Kempner ME; Smith M; Brown J; Dey BR; El-Jawahri A; McAfee SL; Spitzer TR; Ballen KK; Sung AD; Dalton TE; Messina JA; Dettmer K; Liebisch G; Oefner P; Taur Y; Pamer EG; Holler E; Mansour MK; van den Brink MRM; Hohmann E; Jenq RR; Chen YB
Blood Adv; 2018 Apr; 2(7):745-753. PubMed ID: 29592876
[TBL] [Abstract][Full Text] [Related]
8. Treating Steroid Refractory Intestinal Acute Graft-vs.-Host Disease With Fecal Microbiota Transplantation: A Pilot Study.
Qi X; Li X; Zhao Y; Wu X; Chen F; Ma X; Zhang F; Wu D
Front Immunol; 2018; 9():2195. PubMed ID: 30319644
[TBL] [Abstract][Full Text] [Related]
9. Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: two case reports and a review of the literature.
Biernat MM; Urbaniak-Kujda D; Dybko J; Kapelko-Słowik K; Prajs I; Wróbel T
J Int Med Res; 2020 Jun; 48(6):300060520925693. PubMed ID: 32527171
[TBL] [Abstract][Full Text] [Related]
10. Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients.
van Lier YF; Davids M; Haverkate NJE; de Groot PF; Donker ML; Meijer E; Heubel-Moenen FCJI; Nur E; Zeerleder SS; Nieuwdorp M; Blom B; Hazenberg MD
Sci Transl Med; 2020 Aug; 12(556):. PubMed ID: 32801142
[TBL] [Abstract][Full Text] [Related]
11. Potential of Fecal Microbiota Transplantation to Prevent Acute GVHD: Analysis from a Phase II Trial.
Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Kazadi D; Halaweish H; Khan MH; Hoeschen A; Cao Q; Luo X; Kabage AJ; Lopez S; Holtan SG; Weisdorf DJ; Khoruts A; Staley C
Clin Cancer Res; 2023 Dec; 29(23):4920-4929. PubMed ID: 37787998
[TBL] [Abstract][Full Text] [Related]
12. Multi-omics Analysis of a Fecal Microbiota Transplantation Trial Identifies Novel Aspects of Acute GVHD Pathogenesis.
Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Kazadi D; Halaweish H; Khan MH; Hoeschen A; Cao Q; Luo X; Kabage AJ; Lopez S; Ramamoorthy S; Holtan SG; Weisdorf DJ; Khoruts A; Staley C
Cancer Res Commun; 2024 Jun; 4(6):1454-1466. PubMed ID: 38767452
[TBL] [Abstract][Full Text] [Related]
13. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
[TBL] [Abstract][Full Text] [Related]
14. Fecal Microbiota Transplantation for Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation: Expanding the Horizon into Pediatrics.
Gray AN; DeFilipp Z
Transplant Cell Ther; 2023 Aug; 29(8):484-491. PubMed ID: 37169290
[TBL] [Abstract][Full Text] [Related]
15. Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders.
Biagi E; Zama D; Rampelli S; Turroni S; Brigidi P; Consolandi C; Severgnini M; Picotti E; Gasperini P; Merli P; Decembrino N; Zecca M; Cesaro S; Faraci M; Prete A; Locatelli F; Pession A; Candela M; Masetti R
BMC Med Genomics; 2019 Mar; 12(1):49. PubMed ID: 30845942
[TBL] [Abstract][Full Text] [Related]
16. [Fecal microbiota transplantation for graft-versus-host disease in children and adults: methods, clinical effects, safety].
Goloshchapov OV; Chukhlovin AB; Bakin EA; Stanevich OV; Klementeva RV; Shcherbakov AA; Shvetsov AN; Suvorova MA; Bondarenko SN; Kucher MA; Kulagin AD; Zubarovskaya LS; Moiseev IS
Ter Arkh; 2020 Sep; 92(7):43-54. PubMed ID: 33346444
[TBL] [Abstract][Full Text] [Related]
17. Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis.
Cui B; Li P; Xu L; Zhao Y; Wang H; Peng Z; Xu H; Xiang J; He Z; Zhang T; Nie Y; Wu K; Fan D; Ji G; Zhang F
J Transl Med; 2015 Sep; 13():298. PubMed ID: 26363929
[TBL] [Abstract][Full Text] [Related]
18. [Fecal microbiota transplantation for acute graft-versus-host disease of the gut].
Kakihana K
Rinsho Ketsueki; 2017; 58(5):499-505. PubMed ID: 28592766
[TBL] [Abstract][Full Text] [Related]
19. Steroid-resistant intestinal aGVHD and refractory CMV and EBV infections complicated by haplo-HSCT were successfully rescued by FMT and CTL infusion.
Qi L; Huang X; He C; Ji D; Li F
J Int Med Res; 2021 Dec; 49(12):3000605211063292. PubMed ID: 34918995
[TBL] [Abstract][Full Text] [Related]
20. Profiling the Fungal Microbiome after Fecal Microbiota Transplantation for Graft-versus-Host Disease: Insights from a Phase 1 Interventional Study.
van Lier YF; Rolling T; Armijo GK; Zhai B; Haverkate NJE; Meijer E; Nur E; Blom B; Peled JU; van den Brink MRM; Hohl TM; Hazenberg MD; Markey KA
Transplant Cell Ther; 2023 Jan; 29(1):63.e1-63.e5. PubMed ID: 36280104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
